MEPACT Trademark

Trademark Overview

On Thursday, September 16, 2010, a trademark application was filed for MEPACT with the United States Patent and Trademark Office. The USPTO has given the MEPACT trademark a serial number of 79088247. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 17, 2020. This trademark is owned by IDM Pharma SAS. The MEPACT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for cancer treatment
mepact

General Information

Serial Number79088247
Word MarkMEPACT
Filing DateThursday, September 16, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 17, 2020
Registration Number3988069
Registration DateTuesday, July 5, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "MEPACT" followed by a design consisting of an incomplete shaded oval, with a semicircular cutout on the right, in which rests a small shaded circle.
Goods and ServicesPharmaceutical products for cancer treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTAKEDA FRANCE SAS
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressFR
Party NameIDM Pharma SAS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIDM Pharma SAS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameIDM Pharma SAS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Saturday, April 17, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, April 17, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 15, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 17, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, October 17, 2018INVALIDATION PROCESSED
Tuesday, October 9, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 9, 2018CANCELLED SECTION 71
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 1, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 10, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, December 30, 2011FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 14, 2011FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, December 14, 2011FINAL DISPOSITION PROCESSED
Wednesday, October 5, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 5, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 30, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 30, 2011NOTICE OF PUBLICATION
Friday, March 11, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 11, 2011ASSIGNED TO LIE
Sunday, February 20, 2011REFUSAL PROCESSED BY IB
Friday, February 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 16, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 29, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 29, 2010REFUSAL PROCESSED BY MPU
Monday, December 27, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 26, 2010NON-FINAL ACTION WRITTEN
Sunday, December 26, 2010ASSIGNED TO EXAMINER
Friday, November 12, 2010APPLICATION FILING RECEIPT MAILED
Monday, November 8, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 5, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

mepact treatment cancer products pharmaceutical